SCHEMBL24862018

SCHEMBL24862018

CCn1nc(C(C)=O)c2c(N)ncnc21

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.47
▸ PRKDC P78527 3/20 0.47
▸ KDR P35968 5/20 0.46
▸ SRC P12931 5/20 0.46
▸ ABL1 P00519 2/20 0.46
▸ EGFR P00533 2/20 0.46
▸ HCK P08631 2/20 0.46
▸ PIK3CA P42336 2/20 0.46
▸ PIK3CB P42338 2/20 0.46
▸ MTOR P42345 2/20 0.46
▸ PIK3CG P48736 2/20 0.46
▸ EPHB4 P54760 2/20 0.46
▸ PI4KB Q9UBF8 2/20 0.46
▸ ATG7 O95352 1/20 0.46
▸ RET P07949 14/20 0.44
▸ FYN P06241 1/20 0.43
▸ LCK P06239 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10261498 0.78 PIK3CD (0.53) PIK3CDPRKDCKDRSRCABL1
SCHEMBL868744 0.75 PIK3CD (0.51) PIK3CDPRKDCKDRSRCABL1
SCHEMBL15826969 0.75 PIK3CD (0.51) PIK3CDPRKDCKDRSRCABL1
SCHEMBL6926274 0.73 PIK3CD (0.52) PIK3CDPRKDCKDRSRCABL1
SCHEMBL13925849 0.72 PIK3CD (0.46) PIK3CDPRKDCKDRSRCABL1
SCHEMBL19500706 0.72 PIK3CD (0.48) PIK3CDPRKDCKDRSRCABL1
SCHEMBL14577797 0.71 KDR (0.43) PIK3CDPRKDCKDRSRCABL1
SCHEMBL19732713 0.70 RET (0.60) PIK3CDKDRSRCRETLCK
SCHEMBL15826968 0.70 PIK3CD (0.73) PIK3CDPRKDCKDRSRCABL1
SCHEMBL19732764 0.70 RET (0.61) PIK3CDPRKDCKDRSRCABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4116302-A1 COMPOUND AND PREPARATION METHOD THEREOF AND APPLICATION THEREOF IN PREPARATION OF THERAPEUTIC ANTI-CANCER DRUG Tianjin Jikun Medical Technology Co., Ltd. (CN) 2023-01-11 — — EP disclosed
Send feedback